Cite
HARVARD Citation
Zhang, J. et al. (2022). The combination of MnO2@Lipo-coated gefitinib and bevacizumab inhibits the development of non-small cell lung cancer. Drug delivery. pp. 466-477. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, J. et al. (2022). The combination of MnO2@Lipo-coated gefitinib and bevacizumab inhibits the development of non-small cell lung cancer. Drug delivery. pp. 466-477. [Online].